Targeted therapies for certain types of cancer and rare disease offer new hope for these patient populations. But how can we ensure that these treatments are also developed with minority communities in mind?
Moderator: Kemi Olugemo, MD, Executive Medical Director, Neurology Clinical Development, Ionis Pharmaceuticals, Inc.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Speakers:
Kate Burke, MD, Senior Medical Advisor, PatientsLikeMe
Elisabeth Heath, MD, Associate Center Director, Translational Sciences Chair, Genitourinary Oncology Multidisciplinary Team, Karmanos Cancer Institute
Alyshia Merchant, Founder, Making Lupus Look Good